Please assess the completion status of the following clinical trial:

Trial Title: Safety of Dialysate Sodium Individualization in Hemodialysis Patients With Intradialytic Hypotension

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Hemodialysis patients with intradialytic hypotension~Exclusion Criteria:~* Atrial fibrillation~* Bilateral upper extremity arteriovenous access~* Average plasma sodium \>139

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 90 Years
- Healthy Volunteers: f

Study Arms:
- standard dialysate sodium (140 mmol/L) (Type: ACTIVE_COMPARATOR): dialysate sodium (140 mmol/L)
- individualized dialysate sodium (Type: EXPERIMENTAL): individualized dialysate sodium (same concentration as the average pre-HD serum sodium during the baseline period)

Based on this trial design, predict the completion outcome and termination type (if applicable).